JP2022532947A5 - - Google Patents
Info
- Publication number
- JP2022532947A5 JP2022532947A5 JP2021569931A JP2021569931A JP2022532947A5 JP 2022532947 A5 JP2022532947 A5 JP 2022532947A5 JP 2021569931 A JP2021569931 A JP 2021569931A JP 2021569931 A JP2021569931 A JP 2021569931A JP 2022532947 A5 JP2022532947 A5 JP 2022532947A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- fluid sample
- body fluid
- kidney injury
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962852961P | 2019-05-24 | 2019-05-24 | |
| US62/852,961 | 2019-05-24 | ||
| PCT/US2020/034400 WO2020243011A1 (en) | 2019-05-24 | 2020-05-22 | Methods for evaluation and treatment of renal injury based on c-c motif chemokine ligand 14 measurement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532947A JP2022532947A (ja) | 2022-07-20 |
| JP2022532947A5 true JP2022532947A5 (https=) | 2023-05-30 |
Family
ID=73554165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569931A Pending JP2022532947A (ja) | 2019-05-24 | 2020-05-22 | Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220236285A1 (https=) |
| EP (1) | EP3977118A4 (https=) |
| JP (1) | JP2022532947A (https=) |
| CN (1) | CN114207436A (https=) |
| AU (1) | AU2020282321A1 (https=) |
| CA (1) | CA3141817A1 (https=) |
| WO (1) | WO2020243011A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021381364A1 (en) * | 2020-11-18 | 2023-06-22 | Astute Medical, Inc. | Methods and compositions for treatment of renal injury and renal failure |
| US20220284243A1 (en) * | 2021-03-03 | 2022-09-08 | International Business Machines Corporation | Ensemble voting classifiers using adjusted thresholds |
| WO2023168299A1 (en) * | 2022-03-03 | 2023-09-07 | Astute Medical, Inc. | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement |
| JP2025141825A (ja) * | 2024-03-15 | 2025-09-29 | 台北医学大学 | 急性腎臓病予測方法及び予測システム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105556305A (zh) * | 2013-06-05 | 2016-05-04 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
| CN107003301B (zh) * | 2014-10-20 | 2019-11-01 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| JP2020504157A (ja) * | 2017-01-12 | 2020-02-06 | アスチュート メディカル，インコーポレイテッド | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
| US11327082B2 (en) * | 2017-09-13 | 2022-05-10 | B.R.A.H.M.S Gmbh | Proadrenomedullin as a marker for abnormal platelet levels |
-
2020
- 2020-05-22 CN CN202080052788.4A patent/CN114207436A/zh active Pending
- 2020-05-22 AU AU2020282321A patent/AU2020282321A1/en not_active Abandoned
- 2020-05-22 US US17/613,766 patent/US20220236285A1/en not_active Abandoned
- 2020-05-22 WO PCT/US2020/034400 patent/WO2020243011A1/en not_active Ceased
- 2020-05-22 JP JP2021569931A patent/JP2022532947A/ja active Pending
- 2020-05-22 EP EP20814423.8A patent/EP3977118A4/en not_active Withdrawn
- 2020-05-22 CA CA3141817A patent/CA3141817A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532947A5 (https=) | ||
| JP2022046669A5 (https=) | ||
| Nowak et al. | Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes | |
| Kamijo et al. | Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease | |
| Chubb et al. | Biochemical analysis of pleural fluid and ascites | |
| Bagshaw et al. | Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness | |
| JP2016505143A5 (https=) | ||
| Zhang et al. | A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies | |
| JP2021039112A5 (https=) | ||
| Cuartero et al. | Cell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients | |
| JP2017533427A5 (https=) | ||
| JP2020504157A5 (https=) | ||
| JP2022091846A5 (https=) | ||
| HRP20130127T1 (hr) | Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega | |
| JP2013503344A5 (https=) | ||
| JP2016520192A5 (https=) | ||
| Kalansooriya et al. | Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes | |
| JP2015129764A5 (https=) | ||
| Yilmaz et al. | Red blood cell distribution width is a predictor of chronic kidney disease progression and all-cause mortality | |
| JP2021523375A5 (https=) | ||
| JP2013513086A5 (https=) | ||
| Li et al. | Utility of cystatin C-based equations in patients undergoing dialysis | |
| Qurashi et al. | Urinary neutrophil gelatinase-associated lipocalin and the occurrence of delayed graft function after kidney transplant | |
| CN105659094B (zh) | 评估全身炎症反应综合征(sirs)或脓毒症患者的死亡风险的方法 | |
| Zhao et al. | A comparison of prediction equations for estimating glomerular filtration rate in Chinese potential living kidney donors |